跳至主要内容
临床试验/NCT03159338
NCT03159338Unknown不适用

The Effect of Platelet-rich Fibrin on Nerve Regeneration After Bilateral Sagittal Split Osteotomy of the Mandible

Shiraz University of Medical Sciences2 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2017年9月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
25
试验地点
2
主要终点
Two-point discrimination (TPD) test

研究概览

简要总结

Patients who have mandibular deformity and will undergo bilateral sagittal split osteotomy will be included in the study.One side of the osteotomies randomly will be considered as study group and another side as a control group.In the study group , platelet rich fibrin will be placed after osteotomy and before rigid fixation.In the control group, fixation will be done without Platelet-rich Fibrin (PRF).Neurosensory disturbance will be evaluated 6 and 12 months after surgeries.

详细描述

Patients who have mandibular deformity and will undergo bilateral sagittal split osteotomy will be included in the study.One side of the osteotomies randomly will be considered as study group and another side as a control group.In the study group , platelet rich fibrin will be placed after osteotomy and before rigid fixation.In the control group fixation will be done without Platelet-rich Fibrin. Before starting the surgical procedure, 20 mL of venous blood will take and placed in a centrifuge for 12 minutes with 28000rpm. After centrifugation, the cap will be removed from each tube and they will be placed into a sterile rack L-PRF™. Fibrin matrix will prepare. The L-PRF™ will be removed from the tube. Then, the clot right beneath the red blood cell clot will be placed on the surface tray and covered. Five minutes will be waited before removing and using the fibrin matrix.Neurosensory disturbance will be evaluated in 6 and 12 months after osteotomies by two-point discrimination (TPD) test and pin tactile discrimination(PTD) tests.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Single (Participant)

盲法说明

Investigator will be blunt about side of treatmen and control.None of surgical team will be as an investigator.Patients will unware about which side is treatment or control.

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Patients who have class II or III deformity and will undergo bilateral sagittal split osteotomy

排除标准

  • Patients who have bad split or obvious nerve injury during surgery will be removed from study inclusion

研究组 & 干预措施

Control group

Placebo Comparator

In control site , placebo gel will be placed before rigid fixation

干预措施: Placebo (Biological)

treatment group

Active Comparator

One side of osteotomies will be considered as a treatment arm (randomly) which Platelet rich fibrin will be used with rigid fixation

干预措施: Platelet rich fibrin (Biological)

结局指标

主要结局

Two-point discrimination (TPD) test

时间窗: TPD will be assessed after 6 months

Two point discrimination will be measured based on the distance of two points (mm)

Two-point discrimination

时间窗: Two-point discrimination will be evaluated after12 months intervals

Two point discrimination will be measured based on the distance of two points (mm)

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Reza Tabrizi

Assistant professor of oral and maxillofacial surgery

Shiraz University of Medical Sciences

研究点 (2)

Loading locations...

相似试验